Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Undetected Cases Hinder Tuberculosis Control in India
Link ID 4091
Title Undetected Cases Hinder Tuberculosis Control in India
Url http://www.medscape.com/viewarticle/571703?src=rss
Description Although India has made considerable progress in tuberculosis (TB) control, more than a third of TB cases there still go undetected, resulting in delays in disease control, according to the World Health Organization (WHO) Report on Global Tuberculosis Control 2008 released on March 19. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Mar 20, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Getting Surgery Right
  Wrong-side surgery continues to occur with unfortunate regularity. Does your institution know left from right? Annals of Surgery
Category:   Articles > Business of Medicine


2. "Emergiblog" Provides Provocative and Poignant Aspects of Medicine
  An enduring figure in the online nursing community experiences and promotes change.
Medscape Med Students
Category:   Articles > Business of Medicine


3. InterMune Lung Disease Medicine on Fast Track
  Biotechnology company InterMune Inc on Monday said U.S. regulators granted fast-track status for the development of pirfenidone to treat idiopathic pulmonary fibrosis (IPF), a deadly lung disease. Reuters Health Information
Category:   Articles > Business of Medicine


4. Patients, Caregivers, and the Danger of Imaging Studies: The Four Horsemen of the Radiology Apocalyp
  The subject of radiation-induced cancer from CT is controversial, and is disputed, primarily by radiologists, citing lack of scientific evidence.
Medscape Radiology
Category:   Articles > Business of Medicine


5. Tarenflurbil Fails to Meet Primary End Point in Phase 3; End of the Road for Development
  In a brief statement, Myriad Genetics reports that tarenflurbil failed to have a significant effect in mild AD patients in a phase 3 trial and announced that it will not continue development of the compound. Medscape Medical News
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS